Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:28630682

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Jason Roszik · Wei-Lien Wang · John A Livingston · Christina L Roland · Vinod Ravi · Cassian Yee · Patrick Hwu · Andrew Futreal · Alexander J Lazar · Shreyaskumar R Patel · Anthony P Conley

Clinical sarcoma research · 2017 doi:10.1186/s13569-017-0077-3

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:28630682
kind
science-record
content_hash
sha256:e03953fafc7b0de49a33cff61962c95d9053f93eb78c2c6d6e87b36f7fd624b4
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:26Z
updated_at
2026-11-01T21:20:58Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.
doi
10.1186/s13569-017-0077-3
pmid
28630682
authors array · 11 items
[0]
Jason Roszik
[1]
Wei-Lien Wang
[2]
John A Livingston
[3]
Christina L Roland
[4]
Vinod Ravi
[5]
Cassian Yee
[6]
Patrick Hwu
[7]
Andrew Futreal
[8]
Alexander J Lazar
[9]
Shreyaskumar R Patel
[10]
Anthony P Conley
journal
Clinical sarcoma research
year
2017
abstract
BACKGROUND: PRAME (preferentially expressed antigen in melanoma), a member of the cancer-testis antigen family, has been shown to have increased expression in solid tumors, including sarcoma, and PRAME-specific therapies are currently in development for other cancers such as melanoma. METHODS: To map the landscape of PRAME expression in sarcoma, we used publicly available data from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE) projects and determined which sarcoma subtypes and subsets are associated with increased PRAME expression. We also analyzed how PRAME expression correlates with survival and expression of markers related to antigen presentation and T cell function. Furthermore, tumor and normal tissue expression comparisons were performed using data from the genotype-tissue expression (GTEx) project. RESULTS: We found that uterine carcinosarcoma highly overexpresses the PRAME antigen, and synovial sarcomas and multifocal leiomyosarcomas also show high expressions suggesting that PRAME may be an effective target of immunotherapies of these tumors. However, we also discovered that PRAME expression negatively correlates with genes involved in antigen presentation, and in synovial sarcoma MHC class I antigen presentation deficiencies are also present, potentially limiting the efficacy of immunotherapies of this malignancy. CONCLUSIONS: We determined that uterine carcinosarcoma, synovial sarcoma, and leiomyosarcoma patients would potentially benefit from PRAME-specific immunotherapies. Tumor escape through loss of antigen presentation needs to be further studied.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
For comparisons of two groups we performed two-tailed Student’s t-tests.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28630682
locator
sections[5] "Statistical analyses" paragraph 2
quote
For comparisons of two groups we performed two-tailed Student’s t-tests.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
We used publicly available data as described in the “Methods”.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28630682
locator
sections[14] "ack" paragraph 1
quote
We used publicly available data as described in the “Methods”.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
Headline result: uterine carcinosarcoma highly overexpressed PRAME, while synovial sarcoma and multifocal leiomyosarcoma also showed high PRAME expression, suggesting potential benefit from PRAME-specific immunotherapies. The paper analyzed publicly available TCGA and CCLE data and examined PRAME associations with survival and antigen-presentation/T-cell markers; the listed sections do not specify the statistical test used.
kind
qualitative
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:28630682
locator
sections[0] "Abstract" paragraph 3
quote
We found that uterine carcinosarcoma highly overexpresses the PRAME antigen, and synovial sarcomas and multifocal leiomyosarcomas also show high expressions suggesting that PRAME may be an effective target of immunotherapies of these tumors.
[1] object · 3 fields
asset
source:pmid:28630682
locator
sections[0] "Abstract" paragraph 2
quote
To map the landscape of PRAME expression in sarcoma, we used publicly available data from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE) projects and determined which sarcoma subtypes and subsets are associated with increased PRAME expression.
[2] object · 3 fields
asset
source:pmid:28630682
locator
sections[0] "Abstract" paragraph 2
quote
We also analyzed how PRAME expression correlates with survival and expression of markers related to antigen presentation and T cell function.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
Headline result: uterine carcinosarcoma highly overexpressed PRAME, while synovial sarcoma and multifocal leiomyosarcoma also showed high PRAME expression, suggesting potential benefit from PRAME-specific immunotherapies. The paper analyzed publicly available TCGA and CCLE data and examined PRAME associations with survival and antigen-presentation/T-cell markers; the listed sections do not specify the statistical test used.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:28630682
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:28630682
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s13569-017-0077-3
sha256
sha256:0231c1c4c23d464686cedc8994bb5f19abee7753987849767b408cae94d53dec
bytes
17392
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s13569-017-0077-3
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5471883
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
Two-tailed Student’s t-test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
For comparisons of two groups we performed two-tailed Student’s t-tests.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (Two-tailed Student’s t-test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
We used publicly available data as described in the “Methods”.
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 1 item
[0]
source:pmid:28630682
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:31:38Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
36607
completion_tokens
5519
cached_tokens
1824
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:28630682
type
paper
label
pmid:28630682
[1] object · 3 fields
id
source:pmid:28630682
type
manuscript
label
PMID 28630682 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:28630682
type
paper
label
pmid:28630682
[1] object · 3 fields
id
source:pmid:28630682
type
manuscript
label
PMID 28630682 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-28630682
type
extraction
used array · 1 item
[0]
source:pmid:28630682
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:28630682
parent_hash
sha256:b347995f461268bcd4c58303abe864c222c854c5a15ebf72b4823697ec69612c
fork_of
null
gaps array · 6 items
[0]
execution.not_run
[1]
method.reader_named_unmapped
[2]
review.human_critique
[3]
review.independent_reader
[4]
review.machine_critique
[5]
step:obtain_source_data blocked on data:accession_absent
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
ses were performed using microarray and also RNA-sequencing data. The TPM unit was used for RNA-seq, and
[1]
A-sequencing data. The TPM unit was used for RNA-seq, and in the case of microarray we used RMA-n
[2]
e available. When comparing expressions from RNA sequencing from the TCGA and GTEx databases, we used th
[3]
found to be most suitable unit for comparing RNA sequencing data [13]. For the analysis of PRAME express
order_basis
paper_text_order:1920
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
CLE expression analyses were performed using microarray and also RNA-sequencing data. The TPM unit w
[1]
nit was used for RNA-seq, and in the case of microarray we used RMA-normalized data, which is calcul
order_basis
paper_text_order:2410
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:28630682", "kind": "science-record", "revision": 6, "content_hash": "sha256:e03953fafc7b0de49a33cff61962c95d9053f93eb78c2c6d6e87b36f7fd624b4", "created_at": "2026-11-01T15:40:26Z", "updated_at": "2026-11-01T21:20:58Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.", "doi": "10.1186/s13569-017-0077-3", "pmid": "28630682", "authors": ["Jason Roszik", "Wei-Lien Wang", "John A Livingston", "Christina L Roland", "Vinod Ravi", "Cassian Yee", "Patrick Hwu", "Andrew Futreal", "Alexander J Lazar", "Shreyaskumar R Patel", "Anthony P Conley"], "journal": "Clinical sarcoma research", "year": 2017, "abstract": "BACKGROUND: PRAME (preferentially expressed antigen in melanoma), a member of the cancer-testis antigen family, has been shown to have increased expression in solid tumors, including sarcoma, and PRAME-specific therapies are currently in development for other cancers such as melanoma.\nMETHODS: To map the landscape of PRAME expression in sarcoma, we used publicly available data from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE) projects and determined which sarcoma subtypes and subsets are associated with increased PRAME expression. We also analyzed how PRAME expression correlates with survival and expression of markers related to antigen presentation and T cell function. Furthermore, tumor and normal tissue expression comparisons were performed using data from the genotype-tissue expression (GTEx) project.\nRESULTS: We found that uterine carcinosarcoma highly overexpresses the PRAME antigen, and synovial sarcomas and multifocal leiomyosarcomas also show high expressions suggesting that PRAME may be an effective target of immunotherapies of these tumors. However, we also discovered that PRAME expression negatively correlates with genes involved in antigen presentation, and in synovial sarcoma MHC class I antigen presentation deficiencies are also present, potentially limiting the efficacy of immunotherapies of this malignancy.\nCONCLUSIONS: We determined that uterine carcinosarcoma, synovial sarcoma, and leiomyosarcoma patients would potentially benefit from PRAME-specific immunotherapies. Tumor escape through loss of antigen presentation needs to be further studied.", "claims": [{"id": "claim-method", "statement": "For comparisons of two groups we performed two-tailed Student’s t-tests.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28630682", "locator": "sections[5] \"Statistical analyses\" paragraph 2", "quote": "For comparisons of two groups we performed two-tailed Student’s t-tests."}], "state": "complete"}, {"id": "claim-data-access", "statement": "We used publicly available data as described in the “Methods”.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28630682", "locator": "sections[14] \"ack\" paragraph 1", "quote": "We used publicly available data as described in the “Methods”."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Headline result: uterine carcinosarcoma highly overexpressed PRAME, while synovial sarcoma and multifocal leiomyosarcoma also showed high PRAME expression, suggesting potential benefit from PRAME-specific immunotherapies. The paper analyzed publicly available TCGA and CCLE data and examined PRAME associations with survival and antigen-presentation/T-cell markers; the listed sections do not specify the statistical test used.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:28630682", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "We found that uterine carcinosarcoma highly overexpresses the PRAME antigen, and synovial sarcomas and multifocal leiomyosarcomas also show high expressions suggesting that PRAME may be an effective target of immunotherapies of these tumors."}, {"asset": "source:pmid:28630682", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "To map the landscape of PRAME expression in sarcoma, we used publicly available data from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE) projects and determined which sarcoma subtypes and subsets are associated with increased PRAME expression."}, {"asset": "source:pmid:28630682", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "We also analyzed how PRAME expression correlates with survival and expression of markers related to antigen presentation and T cell function."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "Headline result: uterine carcinosarcoma highly overexpressed PRAME, while synovial sarcoma and multifocal leiomyosarcoma also showed high PRAME expression, suggesting potential benefit from PRAME-specific immunotherapies. The paper analyzed publicly available TCGA and CCLE data and examined PRAME associations with survival and antigen-presentation/T-cell markers; the listed sections do not specify the statistical test used.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:28630682"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:28630682", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s13569-017-0077-3", "sha256": "sha256:0231c1c4c23d464686cedc8994bb5f19abee7753987849767b408cae94d53dec", "bytes": 17392, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s13569-017-0077-3", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5471883", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "Two-tailed Student’s t-test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "For comparisons of two groups we performed two-tailed Student’s t-tests."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (Two-tailed Student’s t-test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["We used publicly available data as described in the “Methods”."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:28630682"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:31:38Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 36607, "completion_tokens": 5519, "cached_tokens": 1824}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:28630682", "type": "paper", "label": "pmid:28630682"}, {"id": "source:pmid:28630682", "type": "manuscript", "label": "PMID 28630682 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:28630682", "type": "paper", "label": "pmid:28630682"}, {"id": "source:pmid:28630682", "type": "manuscript", "label": "PMID 28630682 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-28630682", "type": "extraction", "used": ["source:pmid:28630682"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:28630682", "parent_hash": "sha256:b347995f461268bcd4c58303abe864c222c854c5a15ebf72b4823697ec69612c", "fork_of": null, "generation": 5}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ses were performed using microarray and also RNA-sequencing data. The TPM unit was used for RNA-seq, and", "A-sequencing data. The TPM unit was used for RNA-seq, and in the case of microarray we used RMA-n", "e available. When comparing expressions from RNA sequencing from the TCGA and GTEx databases, we used th", "found to be most suitable unit for comparing RNA sequencing data [13]. For the analysis of PRAME express"], "order_basis": "paper_text_order:1920", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["CLE expression analyses were performed using microarray and also RNA-sequencing data. The TPM unit w", "nit was used for RNA-seq, and in the case of microarray we used RMA-normalized data, which is calcul"], "order_basis": "paper_text_order:2410", "id": "assay:2"}]}